470 Participants Needed

Emotion Regulation Therapies for Autism

Recruiting at 1 trial location
KD
AP
Overseen ByAnna-Lisa Pflaum
Age: < 65
Sex: Any
Trial Phase: Academic
Sponsor: University of Pittsburgh
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

Too few clinicians are able and willing to help autistic patients. A recent review identified challenges to mental health service delivery in autism, including a lack of interventions designed for community implementation and limited workforce capacity. It has been argued that improving impairment in emotion regulation has the potential to improve a range of mental health difficulties in autistic people. In this clinical trial, the investigators are comparing two evidence-based interventions for emotion regulation, to determine if one created specifically for autistic people is clinically superior. The interventions will be implemented in the community, through partnering agencies.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your healthcare provider.

What data supports the effectiveness of the treatment The Unified Protocol for Transdiagnostic Treatment of Emotional Disorders?

Research shows that the Unified Protocol (UP) is effective in reducing symptoms of emotional disorders like anxiety and depression, and it improves emotional regulation and quality of life. It works well in both group and virtual formats, making it a flexible option for treating various emotional issues.12345

Is the Unified Protocol safe for humans?

The Unified Protocol (UP) has been studied in various formats and settings, including group and virtual formats, and has shown to be effective for treating emotional disorders without any reported safety concerns in humans.12346

How is the Emotion Awareness and Skills Enhancement Program (EASE) different from other treatments for autism?

The Emotion Awareness and Skills Enhancement Program (EASE), part of the Unified Protocol, is unique because it is a flexible cognitive-behavioral therapy designed to address a range of emotional disorders by focusing on emotional awareness and regulation. Unlike treatments targeting specific disorders, EASE can be personalized to fit individual needs, making it adaptable for various emotional challenges associated with autism.12346

Research Team

CM

Carla Mazefsky, PhD

Principal Investigator

University of Pittsburgh

SW

Susan White, PhD

Principal Investigator

University of Alabama at Birmingham

Eligibility Criteria

This trial is for autistic youth and young adults who have difficulty regulating emotions, as indicated by specific scores on the EDI-Reactivity or Dysphoria scale. Participants must have a professional ASD diagnosis, be able to take part meaningfully, and benefit from the study. They need an adult who can complete assessments and live in Alabama or Pennsylvania with internet access for online activities.

Inclusion Criteria

Communicative ability (verbal or nonverbal)
Clinician judgment that person could meaningfully participate and potentially benefit
Professional diagnosis of ASD
See 4 more

Exclusion Criteria

Intoxication
Acute psychosis
Imminent suicide/homicide threat
See 1 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive either the EASE or UP intervention, each consisting of 16 sessions

16-20 weeks
16 sessions (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment

3 months

Treatment Details

Interventions

  • The Emotion Awareness and Skills Enhancement Program
  • The Unified Protocol
Trial OverviewThe trial compares two emotion regulation therapies: The Emotion Awareness and Skills Enhancement Program designed specifically for autistic individuals, versus The Unified Protocol. It aims to determine which intervention is more effective when implemented through community agencies.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: The Emotion Awareness and Skills EnhancementExperimental Treatment1 Intervention
EASE is a 16-session mindfulness-based intervention (MBI). It emphasizes a small set of core concepts (i.e., mindfulness practices, distress tolerance, encouraging helpful thoughts, self-compassion) that are repeated with consistent language throughout. Emphasis is placed on increasing awareness of gradients of emotional arousal.
Group II: The Unified ProtocolActive Control1 Intervention
UP is a 12-21 session cognitive behavioral therapy (CBT) based treatment. In this study, there will be 16 sessions. UP is focused on identifying emotions and building new coping strategies. It is customizable to meet the needs of the individual.

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Pittsburgh

Lead Sponsor

Trials
1,820
Recruited
16,360,000+

University of Alabama, Tuscaloosa

Collaborator

Trials
49
Recruited
17,900+

Patient-Centered Outcomes Research Institute

Collaborator

Trials
592
Recruited
27,110,000+

Findings from Research

The Unified Protocol (UP) for treating emotional disorders was found to be effective in improving specific symptoms such as depression and obsessive-compulsive disorder in a study of 243 participants over six months.
Participants receiving the group UP showed greater improvements in depressive symptoms and quality of life compared to those receiving individual Treatment as Usual (TAU), highlighting the UP's efficacy in a public health setting.
Unified Protocol in a Group Format for Improving Specific Symptoms of Emotional Disorders in the Spanish Public Health System.Osma, J., Navarro Haro, MV., Peris Baquero, Ó., et al.[2022]
The Unified Protocol (UP) for treating emotional disorders was found to be as effective as established single disorder protocols (SDPs) in reducing symptoms of co-occurring emotional disorders among 179 adults, with significant improvements observed from baseline to post-treatment and at 12-month follow-up.
Both treatment approaches led to large reductions in symptoms of generalized anxiety, social anxiety, and depression, indicating that the UP is a viable and potentially more cost-effective option for treating multiple emotional disorders simultaneously.
Efficacy of the Unified Protocol for transdiagnostic treatment of comorbid psychopathology accompanying emotional disorders compared to treatments targeting single disorders.Steele, SJ., Farchione, TJ., Cassiello-Robbins, C., et al.[2019]
A brief online version of the Unified Protocol for Transdiagnostic Treatment of Emotional Disorders was tested with 19 young adults, showing that 72% attended at least four out of five sessions, indicating good feasibility for this format.
Participants reported that key concepts from the therapy, like understanding emotions and mindfulness, were useful in their daily lives, and there was a significant reduction in anxiety-related life impairment at the 12-week follow-up compared to baseline.
Feasibility and acceptability of a brief, online transdiagnostic psychotherapy for young adults.Dimitropoulos, G., Lindenbach, D., Rowbotham, M., et al.[2023]

References

Unified Protocol in a Group Format for Improving Specific Symptoms of Emotional Disorders in the Spanish Public Health System. [2022]
Efficacy of the Unified Protocol for transdiagnostic treatment of comorbid psychopathology accompanying emotional disorders compared to treatments targeting single disorders. [2019]
Feasibility and acceptability of a brief, online transdiagnostic psychotherapy for young adults. [2023]
Unified Protocol for the transdiagnostic treatment of emotional disorders in virtual and group format in Argentina: three months follow-up of a pilot study [2023]
The Development of the Unified Protocol for the Transdiagnostic Treatment of Emotional Disorders: A Case Study. [2022]
Isolating the Unique Effects of the Unified Protocol Treatment Modules Using Single Case Experimental Design. [2018]